Yumanity Therapeutics Inc YMTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
11.29quote price arrow up+0.24 (+2.17%)
Volume
7,152
Close
11.05quote price arrow down-0.99 (-8.22%)
Volume
587,781
52 week range
8.21 - 27.00
Loading...
  • Open12.14
  • Day High12.40
  • Day Low10.81
  • Prev Close12.04
  • 52 Week High27.00
  • 52 Week High Date10/14/20
  • 52 Week Low8.21
  • 52 Week Low Date08/20/21

Key Stats

  • Market Cap113.93M
  • Shares Out10.31M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta0.70
  • YTD % Change-35

KEY STATS

  • Open12.14
  • Day High12.40
  • Day Low10.81
  • Prev Close12.04
  • 52 Week High27.00
  • 52 Week High Date10/14/20
  • 52 Week Low8.21
  • 52 Week Low Date08/20/21
  • Market Cap113.93M
  • Shares Out10.31M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta0.70
  • YTD % Change-35

RATIOS/PROFITABILITY

  • EPS (TTM)-16.25
  • P/E (TTM)-0.68
  • Fwd P/E (NTM)-2.29
  • EBITDA (MRQ)-54.741M
  • ROE (MRQ)-118.91%
  • Revenue (MRQ)12.54M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-461.27%
  • Debt To Equity (MRQ)37.20%

EVENTS

  • Earnings Date11/15/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Yumanity Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Yumanity Therapeutics Inc., formerly Proteostasis Therapeutics, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of disease-modifying therapies for neurodegenerative diseases. The Company's technology platform enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks. The Company's product candidate, YTX-7739, is in Phase I clinical...
N. Anthony Coles Jr., M.D.
Non-Executive Chairman
Richard Peters M.D., Ph.D.
President
Michael Wyzga
Chief Financial Officer
Ajay Verma M.D., Ph.D.
Executive Vice President
Address
40 GUEST STREET, SUITE 4410
Boston, MA
02135
United States

Top Peers

SYMBOLLASTCHG%CHG
ARDX
Ardelyx Inc
1.31-0.03-2.24%
ABEO
Abeona Therapeutics Inc
1.20-0.04-3.23%
ISR
IsoRay Inc
0.6816+0.018+2.71%
PHAS
PhaseBio Pharmaceuticals Inc
2.89-0.03-1.03%
FSTX
F-Star Therapeutics Inc
7.59+0.62+8.90%